Insider · CIK 0001633660
Cranston Lynda Sarah
Reports to the SEC for 1 company · VANCOUVER, A1
Transactions
26
Companies
1
Filings
17
CIK
0001633660
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-06-30 | HURATuHURA Biosciences, Inc./NVJ Other | — |
| 2020-06-26 | HURATuHURA Biosciences, Inc./NV · Option (Right to Buy)A Award | — |
| 2020-03-31 | HURATuHURA Biosciences, Inc./NVJ Other | — |
| 2019-12-31 | HURATuHURA Biosciences, Inc./NVJ Other | — |
| 2019-09-30 | HURATuHURA Biosciences, Inc./NVJ Other | — |
| 2019-09-05 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2019-09-05 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2019-06-28 | HURATuHURA Biosciences, Inc./NVJ Other | — |
| 2019-04-30 | HURATuHURA Biosciences, Inc./NV · Performance Stock UnitsD Disposition to Issuer | — |
| 2019-03-29 | HURATuHURA Biosciences, Inc./NVJ Other | +$34.79 |
| 2018-12-31 | HURATuHURA Biosciences, Inc./NVJ Other | +$24.275 |
| 2018-11-08 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2018-09-28 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2018-06-29 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2018-03-30 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2017-12-31 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2017-09-29 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2017-07-07 | HURATuHURA Biosciences, Inc./NV · Performance Stock UnitsA Award | — |
| 2017-07-07 | HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award | — |
| 2017-06-30 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2017-06-26 | HURATuHURA Biosciences, Inc./NVP Purchase | +$7,498.8 |
| 2017-03-31 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2016-12-31 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2016-10-03 | HURATuHURA Biosciences, Inc./NVJ Other | +$227.2 |
| 2016-07-18 | HURATuHURA Biosciences, Inc./NVJ Other | +$153.6 |
| 2016-04-29 | HURATuHURA Biosciences, Inc./NV · Series B Preferred StockP Purchase | +$10K |
Recent filings
- 4Cranston Lynda Sarah0001213900-20-016317SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-20-008217SEC(opens sec.gov)
- 4Cranston Lynda Sarah0000905718-20-000016SEC(opens sec.gov)
- 4Cranston Lynda Sarah0000905718-19-000815SEC(opens sec.gov)
- 4Cranston Lynda Sarah0000905718-19-000761SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-19-011880SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-19-007624SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-19-005503SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-19-000053SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-18-015518SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-18-013296SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-18-008712SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-18-003986SEC(opens sec.gov)
- 4Cranston Lynda Sarah0000905718-18-000013SEC(opens sec.gov)
- 4Cranston Lynda Sarah0001213900-17-010210SEC(opens sec.gov)
- 4DelMar Pharmaceuticals, Inc.0001213900-17-007476SEC(opens sec.gov)
- 4DelMar Pharmaceuticals, Inc.0001213900-17-007145SEC(opens sec.gov)
Companies
Address
SUITE 720-999 WEST BROADWAY
VANCOUVER, A1, V5Z 1K5